In recent years, the number of projects related to the application of artificial intelligence (AI) in the health technology sector has grown exponentially. MEDTEQ+, Canada’s pan-Canadian consortium for industrial research and innovation in medical technology and healthcare, has always supported the collaborative development of innovations that make the best use of new enabling technologies that will ultimately improve the health status and quality of life of patients. Proof of this support can be seen in the fact that nearly 40% of our investments are made in promising young AI companies.
As the demand for innovation in the medical technology sector reaches an unprecedented level, the need for AI companies to grow and implement an effective strategy, network, structure and experience are some of the priorities that these companies must address if they are to outperform the competition.
As a true powerhouse of artificial intelligence in the technology and healthcare fields, and with a keen understanding of the challenges that companies face in bringing their products to market, MEDTEQ+ can offer a privileged path for companies working in the field of artificial intelligence, facilitating the growth of their business and ensuring stability within the industry.
This is the case, for example, for Imagia, Aifred Health or Alayacare, three young companies that have benefited from MEDTEQ+’s support since their beginnings. As MEDTEQ+ continues to develop its network and services, the consortium is an essential component for any AI company in the healthcare network.
